Login / Signup
Editorial: risk assessment for chronic hepatitis B patients in the immune tolerant phase-both definition and selection matter.
Yao-Chun Hsu
Yen-Tsung Huang
Published in:
Alimentary pharmacology & therapeutics (2020)
Keyphrases
</>
risk assessment
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
hepatitis b virus
peritoneal dialysis
prognostic factors
patient reported outcomes
liver fibrosis